Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
CAD is the first cause of mortality worldwide today and continues to be a major burden on public health1.
Despite falling CAD mortality rates in Western European countries, the number of CAD patients may actually be increasing, with ageing populations and the improving prognosis of coronary patients due to more effective treatments 2.
CAD by itself is the single most common cause of death in Europe, accounting for over 1.92 million deaths each year. This is true at all ages, including deaths before the age of 65 (figure provided by the University of Oxford).
Interregional differences are even more evident for CAD risk factors: smoking, dietary patterns, levels of physical activity, obesity and diabetes, arterial hypertension and dyslipidemia. The West to East gradient of both CAD prevalence and mortality is associated with the same gradient for the prevalence of risk factors for atherosclerosis. Both are inversely related with both pro capite and national gross product of the European countries.
In the Western world, ischemic stroke has a major public health impact as the first cause of long-term disability and the third leading cause of death. Stroke mortality ranges from 10% to 30%, and survivors remain at risk of recurrent neurological and cardiac ischemic events.
This registry is being undertaken to improve knowledge about the care of patients with CAD and/or PAD. The registry will provide important data on:
This is an international, prospective, observational, longitudinal registry in patients with CICD with a yearly patient follow up over 3 years.
The study will be approved by local institutional review boards and all patients will give informed consent in accordance with national and local guidelines.
All consecutive patients with CICD either scheduled for an elective revascularisation procedure or visited on an ambulatory basis by participating centers.No data will be collected before detailed information is given to the patient and a signed informed consent is obtained.
The Executive Committee of the registry is chaired by Michel Komajda.The 56 ESC member countries have been invited to join this phase of the registry. If you are interested in joining, please contact your national cardiac society.
Michel Komajda (Chairman)Mathieu Kerneis (Research Fellow)Luigi TavazziAldo Maggioni, EORP Scientific Coordinator, ex officio (non-voting)Gabriel StegMarco ValgimigliRoberto FerrariFrancesco Cosentino
The Steering Committee is composed of one National Coordinator per participating country. National Societies are responsible for national coordinators and selection of participating centres. To date, the members are as follows:
Artan Goda (AL)Volha Sujayeva (BY)Assoc. Prof. Arman Postadjian (BG)El Etriby (EG)Peep Laanmets (EE)Harald Rittger (DE)Vakhtang Chumburidze (GE)Constantinos Tsioufis (GR)Robert Klempfner (IL)David Rott (IL)Zoran Olivari (IT) (coordination of cath labs of cardiology departments)Francesco Fedele (IT) (coordination of clinics of general hospitals without interventional facilities)Gani Bajraktari (KV)Erkin Mirrakhimov (KG)Iveta Mintale (LV)Rimvydas Slapikas (LT)Hanna Szwed (PL)Pedro Braga (PT)Dragos Vinereanu (RO)Ana Djordjevic Dikic (RS)Yuri Lopatin (RU)Luis Rodríguez Padial (SP)Mohammed Sami Mourali (TN)
Michel Komajda (Co-Chairman)Franz Weidinger (Co-Chairman)Luigi TavazziAldo Maggioni (EORP)Gabriel StegMarco ValgimigliAlberto CremonesiSerge KownatorRoberto FerrariFrancesco CosentinoMathieu Kerneis (Research Fellow)
The Steering Committee is composed of one National Coordinator per participating country. National Societies are responsible for national coordinators and selection of participating centres.Éric van Belle (FR)Harald Rittger (DE)Constantinos Tsioufis (FR)Zoran Olivari (clinics with cath labs) (IT)Francesco Fedele (clinics without interventional facilities) (IT)Iveta Mintale (LV)Rimvydas Slapikas (LT)Hanna Szwed (PL)Miguel Mendes (PT)E.V. Shlyakhto (RU)
Michel Komajda (Chairman)Mathieu Kerneis (Fellow)Franz WeidingerLuigi TavazziAldo Maggioni (EORP Scientific Coordinator, ex-officio (non-voting))Gabriel StegMarco ValgimigliAlberto CremonesiSerge KownatorRoberto FerrariFrancesco Cosentino
1. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. European heart journal. Jul 2006;27(13):1610-1619.2. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. May 8 1999;353(9164):1547-15573. Steg PG, Bhatt DL, Wilson PW, D'Agostino R, Sr., Ohman EM, Rother J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S. One-year cardiovascular event rates in outpatients with atherothrombosis. Jama. Mar 21 2007;297(11):1197-1206.4. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Rother J, Sievert H, van Sambeek M, Zeller T, Bax J, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu B, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S, Kolh P, Torbicki A, Agewall S, Blinc A, Bulvas M, Cosentino F, De Backer T, Gottsater A, Gulba D, Guzik TJ, Jonsson B, Kesmarky G, Kitsiou A, Kuczmik W, Larsen ML, Madaric J, Mas JL, McMurray JJ, Micari A, Mosseri M, Muller C, Naylor R, Norrving B, Oto O, Pasierski T, Plouin PF, Ribichini F, Ricco JB, Ruilope L, Schmid JP, Schwehr U, Sol BG, Sprynger M, Tiefenbacher C, Tsioufis C, Van Damme H. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). European heart journal. Nov;32(22):2851-2906.
© 2017 European Society of Cardiology. All rights reserved